Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Here’s how a new data dashboard could help KCMO redirect funds to small businesses
A new data dashboard built to better understand Kansas City’s business needs — and guide the city’s response — is not only revolutionary for the metro, said Nia Richardson, it could be the first of its kind, period. Small business advocates already are calling it a win. “I don’t know of any other city or playbook…
Modern world requires entrepreneurs to think like creatives, says KU’s Innovator in Residence
Editor’s note: The University of Kansas’ School of Business is a partner of Startland News. LAWRENCE, Kansas — Building a skill set around creativity is critical to entrepreneurship — especially at a time when careers can be short-lived, said Josh Wexler. “Jobs are no longer for life,” explained the Innovator in Residence at the University…
Grantmaking reboot ‘just one piece of the larger puzzle’ in Kauffman Foundation reset, CEO says
Overhauling the Kauffman Foundation’s grantmaking strategy aligns with a broader, holistic reset for the influential Kansas City organization, said Dr. DeAngela Burns Wallace, emphasizing org-wide moves to deepen the impact and dialogue sparked by its giving. “We’re still engaged in the work happening locally, regionally, and nationally,” said Burns-Wallace, president and CEO of the Ewing…
KC Current’s goalkeeper AD Franch lauded for teaming with WeCodeKC to empower urban youth
AD Franch is more than just a world-class athlete; she’s a true community servant, said Tammy Buckner, founder of WeCodeKC, heaping praise on the KC Current goalkeeper-turned-advocate for technology education in Kansas City. “Her passion and dedication to our students are unmatched,” said Buckner. “Through her partnership, we’ve been able to bring sports and technology…